Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients. [electronic resource]
Producer: 20010322Description: 579-88 p. digitalISSN:- 0022-1899
- Adolescent
- Amino Acid Substitution
- Anti-HIV Agents -- therapeutic use
- Child
- Child, Preschool
- Cohort Studies
- Drug Therapy, Combination
- Female
- Genotype
- HIV Infections -- drug therapy
- HIV Protease -- genetics
- HIV Reverse Transcriptase -- genetics
- HIV-1 -- enzymology
- Humans
- Infant
- Male
- Phylogeny
- Predictive Value of Tests
- Prospective Studies
- Reverse Transcriptase Inhibitors -- therapeutic use
- Sequence Analysis, DNA
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.